These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 15989644)

  • 1. Cholecystokinin-A receptor antagonists: therapies for gastrointestinal disorders.
    D'Amato M; Rovati LC
    Expert Opin Investig Drugs; 1997 Jul; 6(7):819-36. PubMed ID: 15989644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptoid CCK receptor antagonists: pharmacological evaluation of CCKA, CCKB and mixed CCKA/B receptor antagonists.
    Singh L; Field MJ; Hill DR; Horwell DC; McKnight AT; Roberts E; Tang KW; Woodruff GN
    Eur J Pharmacol; 1995 Nov; 286(2):185-91. PubMed ID: 8605955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCKB receptors mediate CCK-8S-induced activation of dorsal hippocampus CA3 pyramidal neurons: an in vivo electrophysiological study in the rat.
    Gronier B; Debonnel G
    Synapse; 1995 Oct; 21(2):158-68. PubMed ID: 8584977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Several roles of CCKA and CCKB receptor subtypes in CCK-8-induced and LiCl-induced taste aversion conditioning.
    Mosher JT; Johnson MF; Birkemo LS; Ervin GN
    Peptides; 1996; 17(3):483-8. PubMed ID: 8735976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCKA and CCKB receptor subtypes both mediate the effects of CCK-8 on myenteric neurons in the guinea-pig ileum.
    Schutte IW; Akkermans LM; Kroese AB
    J Auton Nerv Syst; 1997 Dec; 67(1-2):51-9. PubMed ID: 9470144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypolocomotion induced by peripheral or central injection of CCK in the mouse is blocked by the CCKA receptor antagonist devazepide but not by the CCKB receptor antagonist L-365,260.
    O'Neill MF; Dourish CT; Iversen SD
    Eur J Pharmacol; 1991 Feb; 193(2):203-8. PubMed ID: 2050197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of receptor desensitization to analyse CCKA and CCKB/gastrin receptors coupled to contraction in guinea-pig stomach muscle.
    Bishop LA; Gerskowitch VP; Hull RA; Shankley NP; Black JW
    Br J Pharmacol; 1995 Jan; 114(2):339-48. PubMed ID: 7881733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of cholecystokinin-A and cholecystokinin-B receptors in anxiety.
    Hernandez-Gómez AM; Aguilar-Roblero R; Pérez de la Mora M
    Amino Acids; 2002; 23(1-3):283-90. PubMed ID: 12373548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of two different cholecystokinin receptors in Xenopus oocytes injected with mRNA from rabbit pancreas and rat hippocampus.
    Shigeri Y; Shinohara S; Murata S; Fujimoto M; Kawasaki K
    Jpn J Pharmacol; 1996 Sep; 72(1):9-15. PubMed ID: 8902594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological properties of ureido-acetamides, new potent and selective non-peptide CCKB/gastrin receptor antagonists.
    Bertrand P; Böhme GA; Durieux C; Guyon C; Capet M; Jeantaud B; Boudeau P; Ducos B; Pendley CE; Martin GE
    Eur J Pharmacol; 1994 Sep; 262(3):233-45. PubMed ID: 7813588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCK antagonists: pharmacology and therapeutic interest.
    Wettstein JG; Buéno L; Junien JL
    Pharmacol Ther; 1994; 62(3):267-82. PubMed ID: 7972336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of dexloxiglumide and spiroglumide, two new CCK-receptor antagonists, on gastric emptying and secretion in the rat: evaluation of their receptor selectivity in vivo.
    Scarpignato C; Kisfalvi I; D'Amato M; Varga G
    Aliment Pharmacol Ther; 1996 Jun; 10(3):411-9. PubMed ID: 8791971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of action of cholecystokinin in the canine gastrointestinal tract: role of vasoactive intestinal peptide and nitric oxide.
    Vergara P; Woskowska Z; Cipris S; Fox-Threlkeld JE; Daniel EE
    J Pharmacol Exp Ther; 1996 Oct; 279(1):306-16. PubMed ID: 8859008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholecystokinin-8S increases dynorphin B, aspartate and glutamate release in the fronto-parietal cortex of the rat via different receptor subtypes.
    You ZB; Godukhin O; Goiny M; Nylander I; Ungerstedt U; Terenius L; Hökfelt T; Herrera-Marschitz M
    Naunyn Schmiedebergs Arch Pharmacol; 1997 May; 355(5):576-81. PubMed ID: 9151295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholecystokinin antagonists: pharmacological and therapeutic potential.
    Herranz R
    Med Res Rev; 2003 Sep; 23(5):559-605. PubMed ID: 12789687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mediation by CCKB receptors of the CCK-evoked hyperaemia in rat gastric mucosa.
    Heinemann A; Jocic M; Holzer-Petsche U; Pethö G; Peskar BM; Horwell DC; Holzer P
    Br J Pharmacol; 1995 Oct; 116(4):2274-8. PubMed ID: 8564259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCKA and CCKB receptors are expressed in small cell lung cancer lines and mediate Ca2+ mobilization and clonal growth.
    Sethi T; Herget T; Wu SV; Walsh JH; Rozengurt E
    Cancer Res; 1993 Nov; 53(21):5208-13. PubMed ID: 8221657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of type A and type B CCK receptor binding sites in rat vagus nerve.
    Corp ES; McQuade J; Moran TH; Smith GP
    Brain Res; 1993 Sep; 623(1):161-6. PubMed ID: 8221086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCKB/gastrin receptor antagonists: recent advances and potential uses in gastric secretory disorders.
    Jensen RT
    Yale J Biol Med; 1996; 69(3):245-59. PubMed ID: 9165693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain and gastrointestinal cholecystokinin receptor family: structure and functional expression.
    Wank SA; Pisegna JR; de Weerth A
    Proc Natl Acad Sci U S A; 1992 Sep; 89(18):8691-5. PubMed ID: 1528881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.